<p>, /PRNewswire/ --</p>
<p>原因：罗森律师事务所是一家全球投资者权益律师事务所，提醒在 2025 年 5 月 7 日至 2025 年 8 月 5 日（包括这两个日期）期间购买 LifeMD, Inc.（纳斯达克：LFMD）证券的投资者，注意 2025 年 10 月 27 日的重要首席原告截止日期，这是该事务所首次提起的证券集体诉讼。</p>
<p>那么，接下来怎么办：如果您在集体诉讼期间购买了 LifeMD 证券，您可能有权在不支付任何自付费用或成本的情况下，通过风险代理安排获得赔偿。</p>
<p>下一步该做什么：要加入 LifeMD 集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=43404 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。集体诉讼已被提起。如果您希望担任首席原告，必须在 2025 年 10 月 27 日之前向法院提出申请。首席原告是代表其他集体成员指导诉讼的代表方。</p>
<p>为什么选择罗森律师事务所：我们鼓励投资者选择在领导角色上有成功记录的合格律师事务所。通常，发布通知的事务所没有可比的经验、资源或任何有意义的同行认可。这些事务所中的许多并不真正进行证券集体诉讼，而只是作为中介，转介客户或与实际进行诉讼的律师事务所合作。在选择律师时要明智。罗森律师事务所代表全球投资者，专注于证券集体诉讼和股东衍生诉讼。罗森律师事务所曾在当时获得针对一家中国公司的最大证券集体诉讼和解。该事务所于 2017 年被 ISS 证券集体诉讼服务评选为证券集体诉讼和解数量第一。自 2013 年以来，该事务所每年均排名前四，并为投资者追回了数亿美元。仅在 2019 年，该事务所就为投资者争取了超过 4.38 亿美元的赔偿。在 2020 年，创始合伙人 Laurence Rosen 被 law360 评选为原告律师界的巨头。该事务所的许多律师已被 Lawdragon 和 Super Lawyers 认可。</p>
<p>案件详情：根据诉讼， defendants 在集体诉讼期间做出了实质性虚假和/或误导性陈述，和/或未能披露以下内容：（1）defendants 严重夸大了 LifeMD 的竞争地位；（2）defendants 在提高 LifeMD 的 2025 年指导时表现出鲁莽，因为他们没有正确考虑 LifeMD 的 RexMD 部门的客户获取成本上升，以及与销售旨在治疗肥胖的药物（包括 Wegovy 和 Zepbound）相关的客户获取成本；（3）因此， defendants 关于 LifeMD 的业务、运营和前景的陈述在所有相关时间都是实质性虚假和误导的，和/或缺乏合理依据。当真实细节进入市场时，诉讼声称投资者遭受了损失。</p>
<p>要加入 LifeMD 集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=43404 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。</p>
<p>尚未认证集体。直到集体被认证，您不会被律师代表，除非您聘请一位。您可以选择自己选择的律师。您也可以保持缺席集体成员的身份，此时不采取任何行动。投资者分享任何潜在未来赔偿的能力并不依赖于担任首席原告。</p>
<p>请关注我们的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm 或在 Twitter 上：https://twitter.com/rosen_firm 或在 Facebook 上：https://www.facebook.com/rosenlawfirm。</p>
<p>律师广告。之前的结果并不保证类似的结果。</p>
<p>联系信息：</p>
<p>Laurence Rosen, Esq.</p>
<p>Phillip Kim, Esq.</p>
<p>罗森律师事务所，P.A.</p>
<p>275 Madison Avenue, 40th Floor</p>
<p>纽约， NY 10016</p>
<p>电话: (212) 686-1060</p>
<p>免费电话: (866) 767-3653</p>
<p>传真: (212) 202-3827</p>
<p>[email protected]</p>
<p>www.rosenlegal.com</p>
<p>来源：罗森律师事务所，P.A.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTIxJk5ld3NJdGVtSWQ9REM3Nzk0OCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MjExMTU0UFJfTkVXU19VU1BSX19fX19EQzc3OTQ4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTIxJk5ld3NJdGVtSWQ9REM3Nzk0OCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MjExMTU0UFJfTkVXU19VU1BSX19fX19EQzc3OTQ4"/></p>

LFMD

<p>罗森律师事务所提醒在 2025 年 5 月 7 日至 2025 年 8 月 5 日期间购买了 LifeMD, Inc.（纳斯达克代码：LFMD）证券的投资者，注意 2025 年 10 月 27 日是提起证券欺诈集体诉讼的截止日期。该诉讼指控 LifeMD 就其竞争地位和财务指引做出了误导性陈述，导致投资者遭受损失。感兴趣的方可以在没有前期费用的情况下加入集体诉讼。罗森律师事务所在证券诉讼方面有着良好的业绩记录，鼓励投资者选择合格的法律顾问</p>

<p>, /PRNewswire/ --</p>
<div class="lb-trans"><p>, /PRNewswire/ --</p>
</div><p>Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the &#34;Class Period&#34;), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.</p>
<div class="lb-trans"><p>原因：罗森律师事务所是一家全球投资者权益律师事务所，提醒在 2025 年 5 月 7 日至 2025 年 8 月 5 日（包括这两个日期）期间购买 LifeMD, Inc.（纳斯达克：LFMD）证券的投资者，注意 2025 年 10 月 27 日的重要首席原告截止日期，这是该事务所首次提起的证券集体诉讼。</p>
</div><p>So what: If you purchased LifeMD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.</p>
<div class="lb-trans"><p>那么，接下来怎么办：如果您在集体诉讼期间购买了 LifeMD 证券，您可能有权在不支付任何自付费用或成本的情况下，通过风险代理安排获得赔偿。</p>
</div><p>What to do next: To join the LifeMD class action, go to https://rosenlegal.com/submit-form/?case_id=43404 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 27, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.</p>
<div class="lb-trans"><p>下一步该做什么：要加入 LifeMD 集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=43404 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。集体诉讼已被提起。如果您希望担任首席原告，必须在 2025 年 10 月 27 日之前向法院提出申请。首席原告是代表其他集体成员指导诉讼的代表方。</p>
</div><p>Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.</p>
<div class="lb-trans"><p>为什么选择罗森律师事务所：我们鼓励投资者选择在领导角色上有成功记录的合格律师事务所。通常，发布通知的事务所没有可比的经验、资源或任何有意义的同行认可。这些事务所中的许多并不真正进行证券集体诉讼，而只是作为中介，转介客户或与实际进行诉讼的律师事务所合作。在选择律师时要明智。罗森律师事务所代表全球投资者，专注于证券集体诉讼和股东衍生诉讼。罗森律师事务所曾在当时获得针对一家中国公司的最大证券集体诉讼和解。该事务所于 2017 年被 ISS 证券集体诉讼服务评选为证券集体诉讼和解数量第一。自 2013 年以来，该事务所每年均排名前四，并为投资者追回了数亿美元。仅在 2019 年，该事务所就为投资者争取了超过 4.38 亿美元的赔偿。在 2020 年，创始合伙人 Laurence Rosen 被 law360 评选为原告律师界的巨头。该事务所的许多律师已被 Lawdragon 和 Super Lawyers 认可。</p>
</div><p>Details of the case: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated LifeMD's competitive position; (2) defendants were reckless in raising LifeMD's 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and (3) as a result, defendants' statements about LifeMD's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.</p>
<div class="lb-trans"><p>案件详情：根据诉讼， defendants 在集体诉讼期间做出了实质性虚假和/或误导性陈述，和/或未能披露以下内容：（1）defendants 严重夸大了 LifeMD 的竞争地位；（2）defendants 在提高 LifeMD 的 2025 年指导时表现出鲁莽，因为他们没有正确考虑 LifeMD 的 RexMD 部门的客户获取成本上升，以及与销售旨在治疗肥胖的药物（包括 Wegovy 和 Zepbound）相关的客户获取成本；（3）因此， defendants 关于 LifeMD 的业务、运营和前景的陈述在所有相关时间都是实质性虚假和误导的，和/或缺乏合理依据。当真实细节进入市场时，诉讼声称投资者遭受了损失。</p>
</div><p>To join the LifeMD class action, go to https://rosenlegal.com/submit-form/?case_id=43404 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.</p>
<div class="lb-trans"><p>要加入 LifeMD 集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=43404 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。</p>
</div><p>No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p>
<div class="lb-trans"><p>尚未认证集体。直到集体被认证，您不会被律师代表，除非您聘请一位。您可以选择自己选择的律师。您也可以保持缺席集体成员的身份，此时不采取任何行动。投资者分享任何潜在未来赔偿的能力并不依赖于担任首席原告。</p>
</div><p>Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.</p>
<div class="lb-trans"><p>请关注我们的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm 或在 Twitter 上：https://twitter.com/rosen_firm 或在 Facebook 上：https://www.facebook.com/rosenlawfirm。</p>
</div><p>Attorney Advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律师广告。之前的结果并不保证类似的结果。</p>
</div><p>Contact Information:</p>
<div class="lb-trans"><p>联系信息：</p>
</div><p>Laurence Rosen, Esq.</p>
<div class="lb-trans"><p>Laurence Rosen, Esq.</p>
</div><p>Phillip Kim, Esq.</p>
<div class="lb-trans"><p>Phillip Kim, Esq.</p>
</div><p>The Rosen Law Firm, P.A.</p>
<div class="lb-trans"><p>罗森律师事务所，P.A.</p>
</div><p>275 Madison Avenue, 40th Floor</p>
<div class="lb-trans"><p>275 Madison Avenue, 40th Floor</p>
</div><p>New York, NY 10016</p>
<div class="lb-trans"><p>纽约， NY 10016</p>
</div><p>Tel: (212) 686-1060</p>
<div class="lb-trans"><p>电话: (212) 686-1060</p>
</div><p>Toll Free: (866) 767-3653</p>
<div class="lb-trans"><p>免费电话: (866) 767-3653</p>
</div><p>Fax: (212) 202-3827</p>
<div class="lb-trans"><p>传真: (212) 202-3827</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>www.rosenlegal.com</p>
<div class="lb-trans"><p>www.rosenlegal.com</p>
</div><p>SOURCE THE ROSEN LAW FIRM, P. A.</p>
<div class="lb-trans"><p>来源：罗森律师事务所，P.A.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTIxJk5ld3NJdGVtSWQ9REM3Nzk0OCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MjExMTU0UFJfTkVXU19VU1BSX19fX19EQzc3OTQ4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC77948&amp;Transmission_Id=202509211154PR_NEWS_USPR_____DC77948&amp;DateId=20250921"/></p>

LFMD 投资者有机会主导由 Rosen 律师事务所首次提起的 LifeMD, Inc.证券欺诈诉讼